Alzheimer’s disease biological PET staging using plasma p217+tau

Alzheimer’s disease biological PET staging using plasma p217+tau

Abstract Background Plasma phospho-tau biomarkers, such as p217+tau, excel at identifying Alzheimer’s disease (AD) neuropathology. However, their ability to substitute for tau PET to identify AD biological stage is unclear. Methods Participants included 248 cognitively unimpaired (CU) and 227 cognit...

Full description

Saved in:
Bibliographic Details
Main Authors: Azadeh Feizpour, Vincent Doré, Natasha Krishnadas, Pierrick Bourgeat, James D. Doecke, Ziad S. Saad, Gallen Triana-Baltzer, Simon M. Laws, Rosita Shishegar, Kun Huang, Christopher Fowler, Larry Ward, Colin L. Masters, Jurgen Fripp, Hartmuth C. Kolb, Victor L. Villemagne, Christopher C. Rowe
Format: Article
Language:English
Published: Nature Portfolio 2025-02-01
Series:Communications Medicine
Online Access:https://doi.org/10.1038/s43856-025-00768-z
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first

Similar Items